June 9 (Reuters) - Immuron Ltd (IMC) :
- US DOD NAVAL MEDICAL RESEARCH CENTER REQUESTS MEETING WITH FDA FOR GUIDANCE ON TWO PHASE 2 TRIALS TO PREVENT ACUTE INFECTIOUS DIARRHEA
- IMMURON LTD - TWO HUMAN PHASE II CLINICAL TRIALS TO BE CONDUCTED IN 2021
- IMMURON - ONE TRIAL TO FOCUS ON ABILITY OF HYPERIMMUNE PRODUCT TO PROTECT VOLUNTEERS AGAINST MODERATE TO SEVERE CAMPYLOBACTERIOSIS
- IMMURON - SECOND TRIAL WILL FOCUS ON ETEC INFECTIONS
- IMMURON LTD - NMRC PLANS TO FILE IND APPLICATION LATER THIS YEAR, COMMENCE PHASE 2 CLINICAL STUDIES DURING H1 2021
News: IMC Immuron Says US DOD Naval Medical Research Center Requests Meeting With FDA On Two Phase...
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.29M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3018 | 8.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.0¢ | 124085 | 2 |
View Market Depth
| Last trade - 10.04am 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
9.0¢ |
Change
0.000 ( 2.27 %) |
||||
| Open | High | Low | Volume | ||
| 9.0¢ | 9.0¢ | 9.0¢ | 39912 | ||
| Last updated 10.27am 17/06/2024 ? | |||||
| IMC (ASX) Chart |
Day chart unavailable